Chu, Y.-D.; Kee, K.-M.; Lin, W.-R.; Lai, M.-W.; Lu, S.-N.; Chung, W.-H.; Pang, S.-T.; Yeh, C.-T.
SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer. Biomedicines 2021, 9, 1819.
https://doi.org/10.3390/biomedicines9121819
AMA Style
Chu Y-D, Kee K-M, Lin W-R, Lai M-W, Lu S-N, Chung W-H, Pang S-T, Yeh C-T.
SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer. Biomedicines. 2021; 9(12):1819.
https://doi.org/10.3390/biomedicines9121819
Chicago/Turabian Style
Chu, Yu-De, Kwong-Ming Kee, Wey-Ran Lin, Ming-Wei Lai, Sheng-Nan Lu, Wen-Hung Chung, See-Tong Pang, and Chau-Ting Yeh.
2021. "SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer" Biomedicines 9, no. 12: 1819.
https://doi.org/10.3390/biomedicines9121819
APA Style
Chu, Y.-D., Kee, K.-M., Lin, W.-R., Lai, M.-W., Lu, S.-N., Chung, W.-H., Pang, S.-T., & Yeh, C.-T.
(2021). SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer. Biomedicines, 9(12), 1819.
https://doi.org/10.3390/biomedicines9121819